CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Glucagon-only bionic pancreas - glucagon +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02966275
NCT02966275N/ACompleted
CompareCT.gov

Closed-Loop Glucagon Administration For The Automated Treatment Of Post-Bariatric Hypoglycemia

Massachusetts General Hospital·interventional·Posted Nov 17, 2016·Updated Dec 13, 2018

In Brief

A clinical study evaluating Glucagon-only bionic pancreas - glucagon and Glucagon-only bionic pancreas - placebo for Hypoglycemia. Completed, enrolled 10 participants across 1 site.

Detailed Summary

This study is to test our automated hypoglycemia prevention and treatment device (glucagon-only bionic pancreas) in subjects that have undergone post-bariatric surgery that are experiencing symptoms of hypoglycemia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypoglycemia
CountriesUnited States
CollaboratorsJoslin Diabetes Center

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedNov 17, 2016
Enrollment StartSep 1, 2016
Primary CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 9.6 years ago

Interventions

Glucagon-only bionic pancreas - glucagondevice

A computer algorithm will automatically deliver glucagon based on the signal from a minimally invasive continuous glucose monitor.

Glucagon-only bionic pancreas - placebodevice

A computer algorithm will automatically deliver placebo based on the signal from a minimally invasive continuous glucose monitor.